Delivery Order SPE2DX22D0010-SPE2D825FJF29
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,459.67 on July 22, 2025, for the supply of Concerta ER Tabs 36mg. This firm fixed price contract, which is scheduled for completion by July 23, 2025, represents a competitive award with no set-aside designation and is funded through the Defense Logistics Agency's Medical Supply Chain division. The place of performance is located at the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $18,949.34 on August 12, 2025, for the supply of Concerta ER Tabs 36mg. The contract, which is set to be completed by August 13, 2025, is funded by the Medical Supply Chain, a defense-focused federal agency supporting military and veteran healthcare systems. This delivery order is a child contract issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 4, 2025, for the supply of Concerta ER 36 mg tablets (100 count units) with a ceiling value of $4,310.92. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is scheduled for completion by September 5, 2025. The award fulfills the federal government's pharmaceutical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, was awarded a delivery order on September 10, 2025, for the supply of Concerta ER 36 mg tablets (100 count) valued at $17,812.02. This competitively awarded, firm fixed-price delivery order has a completion date of September 11, 2025, and represents a child contract under the Defense Logistics Agency's broader pharmaceutical supply framework. The contract type and compressed timeline indicate...
- The U.S. Department of Defense's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,205.60 for Concerta ER Tablets 54mg, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order represents a single transaction under the company's broader relationship with the Defense Logistics Agency. The contract was executed on July 29, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $9,289.80 by the Defense Logistics Agency (DLA) on July 18, 2025, for the supply of Concerta ER 36 mg tablets (100-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 21, 2025. The place of performance is listed as Conshohocken, Pennsylvania, where...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency valued at $5,002.74 for 100 tablets of Concerta ER 54 mg on September 10, 2025, with an ultimate completion date of September 11, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award through open competition. The place of performance is located in Conshohocken, Pennsylvania. This...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $28,591.14 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Concerta ER Tablets 36mg. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract requires completion by July 28, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Concerta ER 27 mg tablets (100 count) with a contract ceiling value of $11,539.08. This competitively awarded, non-set-aside delivery order carries a firm fixed price and is scheduled for completion by July 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform work at its corporate...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 30, 2025, for the supply of Concerta ER 18 mg tablets (100-count units) with a contract value of $5,679.26. The award is a firm fixed-price delivery order with an ultimate completion date of July 31, 2025, and represents a non-competitive set-aside contract. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FJF29Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $41,982.42 on September 9, 2025, for the supply of Concerta ER Tabs 27mg. The contract, which is not set-aside and was competitively awarded, is scheduled for completion by September 10, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is funded through the Defense Logistics Agency's Medical Supply Chain, which procures pharmaceutical and medical products to support military healthcare operations. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, including specialty drugs, generics, vaccines, and medical devices to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. AmerisourceBergen's demonstrated capability to fulfill federal medical procurement requirements across multiple therapeutic domains, combined with its significant prime vendor contract, positions the company as a critical supplier for military pharmaceutical needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $42.0k | 9/9/25 |